1. Market Research
  2. > Biotechnology
  3. > Genomics Market Trends
Biomarker Technologies Market by Profiling, Research Area, Application - Global Forecast to 2022

Biomarker Technologies: Global Forecast until 2022

  • May 2018
  • 130 pages
  • ID: 5391645
In this report:
According to the Tufts Center for the Study of Drug Development's Impact Report, ##% of cancer compounds and ##% of non-oncology compounds in clinical trials have some form of biomarker drug label for the development of targeted therapies.
In 2017, the biopsy segment is expected to account for the largest share of ~##% of the global cancer biomarkers market.

Summary

Table of Contents

Search Inside

The biomarker technologies market is estimated to rise at a compound annual growth rate of 9.70 percent.

The biomarker technologies market is forecasted to reach ~$74.5B in 2022 from ~$47.0B in 2017, at a compound annual growth rate (CAGR) of 9.7% during the forecast horizon

The rise of this market is mainly influenced by growing healthcare expenditure and the growth in R&D funding.Other important factors aiding the increase of this market contain the rising utility of biomarkers for diagnostic purposes and new initiatives for biomarker research.

Also, the emergence of companion diagnostics has further intensified biomarker R&D activities.Nevertheless, significant capital investments are required for the discovery, development, and validation of biomarkers.

This is a main factor restraining the rise of the biomarker technologies market.

Immunoassays held the most important share of the biomarker technologies market, by profiling technology, in 2017.

Established on profiling technology, the biomarker technologies market is categorized into immunoassay, PCR, imaging technology, mass spectrometry, NGS, chromatography, cytogenetics, and other technologies.The immunoassay segment recorded for the biggest share of the market.

This industry segment is further divided into the ELISA, western blot, and protein microarray segment.The protein microarray segment is anticipated to grow at the quickest pace during the outlook period, primarily due to its growing use in drug discovery.

Furthermore, it reduces the time taken, costs, and reagent consumption. This sector is influenced by advances in the field of proteomics and improvements in the field of recombinant proteins.

Genomics held the most important share of the biomarker technologies market, by research area, in 2017

Established on research area, this industry is categorized into genomics, proteomics, metabolomics, and other research areas. The focus on biomarker research in the field of genomics is increasing with the advent of innovative technologies including NGS, microarrays, and dPCR; this is supporting industry growth.

Cancer was expected to dominate the biomarker technologies market, by disease indication, in 2017

Established on disease indication, the biomarker technologies market is categorized into cancer, infectious diseases, autoimmune disorders, neurological disorders, cardiovascular disorders, and other disease indications. Cancer recorded for the biggest share of the biomarker technologies market, as biomarkers have main applications in cancer research, diagnostics, and treatment.

Break-up profile of primaries:

• By Company category: Tier 1 - 42.0 percent, Tier 2 - 37.0 percent, and Tier 3 - 21%.

• By Description: C-suite - 34.0 percent, D-level - 42.0 percent, and Others - 24.0 percent

• By Area: North America continent - 32.0 percent, Europe (EU) - 30.0 percent, Asia area - 24.0 percent, and rest of the world - 14.0 percent

The top players in this sector are Agilent Technologies (NYSE:A), Thermo Fisher Scientific, Roche, Waters Corporation, Danaher (NYSE:DHR), Shimadzu (TYO:7701), and Bio-Rad Laboratories.

Segment Research

In this business report, the biomarker technologies market is broken down by test type, product, application, profiling technology, disease indication, system, and research type.Specific segments have also been studied based on application-clinical diagnostics, drug discovery & development, and applied analysis.

The biomarker systems market has also been classified based on products used.

Why acquiring this study can help you:

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on the portfolios of the top actors in the biomarker technologies market. The market research examines the sector by test type, product, application, profiling technology, disease indication, system, research type, and area.

• Product Development/Innovative products: In-depth understanding on up-on-coming technologies, Research&development activities, and launches of new product in the biomarker technologies market.

• Market Development: Highlighted information about lucrative emerging markets-the report examines the industries for biomarker technologies market products across localities.

• industry diversification: Complete information about recent products, untapped areas, and recent evolutions in the biomarker technologies market.

• opposing assessment: Detailed assessment of strategies, products, and manufacturing capabilities of main actors in the biomarker technologies market for mass spectrometry and chromatography.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Diabetes Assays - Medical Devices Pipeline Assessment, 2018

Diabetes Assays - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • July 2018
  • by GlobalData

Diabetes Assays - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Diabetes Assays - Medical Devices Pipeline Assessment, 2018" provides an overview of Diabetes ...

Specific Proteins - Medical Devices Pipeline Assessment, 2018

Specific Proteins - Medical Devices Pipeline Assessment, 2018

  • $ 4000
  • Industry report
  • July 2018
  • by GlobalData

Specific Proteins - Medical Devices Pipeline Assessment, 2018SummaryGlobalData’s Medical Devices sector report, “Specific Proteins - Medical Devices Pipeline Assessment, 2018" provides an overview ...

Cardiac Biomarkers: Technologies and Global Markets

Cardiac Biomarkers: Technologies and Global Markets

  • $ 5500
  • Industry report
  • June 2018
  • by BCC Research

Report ScopeThe principal objectives of this report are to: - Identify viable technology drivers through a comprehensive look at various platform technologies for cardiac marker segments of the diagnostic ...


ref:plp2018

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on